Tommy G. Thompson is a corporate insider at UNITED THERAPEUTICS Corp (UTHR). Thompson's filing history also covers TherapeuticsMD, Inc. (TXMD). Thompson has reported 9 insider filings with the SEC since 2025. The most recent filing was in July 2026.
Every role Tommy G. Thompson has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
UNITED THERAPEUTICS Corp (UTHR)1 filingUpdated Aug 30, 2026
Tommy G. Thompson files SEC Form 4 reports at UNITED THERAPEUTICS Corp (UTHR). 8 SEC Form 4 filings on record going back to 2025, most recently on 23 July 2026. Most recent open-market trade: sold $168K of UTHR on 26 March 2026. Lifetime open-market purchases: $14K. Lifetime open-market sales: $4.66M.
Every recent SEC Form 4 transaction Tommy G. Thompson has reported, most recent first.
InsiderAlpha's records for Tommy G. Thompson go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $14K (1 buy totaling $14K). The largest single buy on record is $14K of TXMD in 2025. Sales side: 6 recorded sales totaling $4.66M, so the filing history runs sell-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Tommy G. Thompson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Tommy G. Thompson is a corporate insider of UNITED THERAPEUTICS Corp (UTHR). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
1 primary Form 4 filing in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchase ($14K) and 6 open-market sales ($4.66M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$UTHR UNITED THERAPEUTICS Corp275 shares @ $537.62$148K